Globus Medical, Inc. (BMV:GMED)
Mexico · Delayed Price · Currency is MXN 1,067.00
-13.00 (-1.20%)
At close: Oct 2, 2025
Globus Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2010 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2010 - 2019 |
Net Income | 356.65 | 102.98 | 122.87 | 190.17 | 149.19 | 102.29 | Upgrade |
Depreciation & Amortization | 271.88 | 254.02 | 144.73 | 68.25 | 69.87 | 62.87 | Upgrade |
Stock-Based Compensation | 50.94 | 54.19 | 52.74 | 32.81 | 30.59 | 27.07 | Upgrade |
Other Adjustments | 66.22 | 206.99 | 39.75 | -7.5 | 43.88 | 44.15 | Upgrade |
Change in Receivables | 66.54 | -78.06 | -49.91 | -50.84 | -25.9 | 10.7 | Upgrade |
Changes in Inventories | -18.73 | -29.86 | -70.33 | -61.75 | -11.97 | -50.11 | Upgrade |
Changes in Accounts Payable | 2.02 | 17.66 | -14.22 | 14.42 | 3.68 | -6.35 | Upgrade |
Changes in Accrued Expenses | 20.13 | 5.02 | 17.13 | 6.09 | 17.9 | 17.61 | Upgrade |
Changes in Income Taxes Payable | -58.78 | -13.38 | -0.41 | -2.89 | 5.21 | 1.66 | Upgrade |
Changes in Other Operating Activities | 3.91 | 1.06 | 1.15 | -10.29 | -6.18 | -11.09 | Upgrade |
Operating Cash Flow | 669.16 | 520.64 | 243.5 | 178.47 | 276.27 | 198.79 | Upgrade |
Operating Cash Flow Growth | 155.60% | 113.81% | 36.44% | -35.40% | 38.98% | 15.59% | Upgrade |
Capital Expenditures | -141.73 | -115.43 | -78.27 | -74.05 | -56.9 | -63.66 | Upgrade |
Purchases of Investments | - | -113.5 | -100.64 | -419.53 | -622.36 | -223.54 | Upgrade |
Proceeds from Sale of Investments | - | 70.52 | 777.91 | 414.65 | 337.81 | 203.36 | Upgrade |
Payments for Business Acquisitions | - | -17.64 | -296.03 | -31.44 | -34.49 | -33.48 | Upgrade |
Investing Cash Flow | -286.81 | -176.05 | 302.97 | -110.36 | -375.94 | -117.32 | Upgrade |
Issuance of Common Stock | 108.71 | 110.44 | 12.4 | 41.72 | 63.5 | 72.32 | Upgrade |
Repurchase of Common Stock | -3.73 | -92.52 | -236.18 | -144.49 | - | -104.67 | Upgrade |
Net Common Stock Issued (Repurchased) | 104.98 | 17.92 | -223.78 | -102.78 | 63.5 | -32.35 | Upgrade |
Other Financing Activities | -19.56 | -45.62 | -8.04 | -7.19 | -9.35 | -6.32 | Upgrade |
Financing Cash Flow | -581.02 | -27.7 | -231.82 | -109.96 | 54.15 | -38.66 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 17.69 | 0.26 | 2.18 | -0.75 | -0.81 | 0.87 | Upgrade |
Net Cash Flow | -180.98 | 317.15 | 316.83 | -42.6 | -46.33 | 43.67 | Upgrade |
Beginning Cash & Cash Equivalents | 410.42 | 467.29 | 150.47 | 193.07 | 239.4 | 195.72 | Upgrade |
Ending Cash & Cash Equivalents | 229.45 | 784.44 | 467.29 | 150.47 | 193.07 | 239.4 | Upgrade |
Free Cash Flow | 527.43 | 405.21 | 165.23 | 104.42 | 219.38 | 135.14 | Upgrade |
Free Cash Flow Growth | 30.16% | 145.25% | 58.23% | -52.40% | 62.34% | 33.50% | Upgrade |
FCF Margin | 20.08% | 16.08% | 10.53% | 10.21% | 22.90% | 17.13% | Upgrade |
Free Cash Flow Per Share | 3.81 | 2.94 | 1.44 | 1.02 | 2.12 | 1.34 | Upgrade |
Levered Free Cash Flow | 435.36 | 222.09 | 122.65 | 129.96 | 170.8 | 53.22 | Upgrade |
Unlevered Free Cash Flow | 343.81 | 270.89 | 91.56 | 118.58 | 164.27 | 41.55 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.